Global Cord Blood (CORBF) Competitors $0.75 0.00 (0.00%) As of 10/8/2025 Add Compare Share Share Competitors Stock AnalysisChartCompetitorsSEC FilingsShort InterestTrendsBuy This Stock CORBF vs. NAKA, AIRS, TALK, AGL, SBC, EHAB, TOI, LFMD, VMD, and XGNShould you be buying Global Cord Blood stock or one of its competitors? The main competitors of Global Cord Blood include KindlyMD (NAKA), AirSculpt Technologies (AIRS), Talkspace (TALK), Agilon Health (AGL), SBC Medical Group (SBC), Enhabit (EHAB), Oncology Institute (TOI), LifeMD (LFMD), Viemed Healthcare (VMD), and Exagen (XGN). These companies are all part of the "healthcare" industry. Global Cord Blood vs. Its Competitors KindlyMD AirSculpt Technologies Talkspace Agilon Health SBC Medical Group Enhabit Oncology Institute LifeMD Viemed Healthcare Exagen Global Cord Blood (NYSE:CORBF) and KindlyMD (NASDAQ:NAKA) are both small-cap medical companies, but which is the better stock? We will contrast the two companies based on the strength of their media sentiment, valuation, analyst recommendations, profitability, dividends, institutional ownership, risk and earnings. Do analysts prefer CORBF or NAKA? KindlyMD has a consensus target price of $8.00, suggesting a potential upside of 753.15%. Given KindlyMD's stronger consensus rating and higher probable upside, analysts plainly believe KindlyMD is more favorable than Global Cord Blood.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Global Cord Blood 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00KindlyMD 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00 Is CORBF or NAKA more profitable? Global Cord Blood has a net margin of 0.00% compared to KindlyMD's net margin of -244.00%. Global Cord Blood's return on equity of 0.00% beat KindlyMD's return on equity.Company Net Margins Return on Equity Return on Assets Global Cord BloodN/A N/A N/A KindlyMD -244.00%-131.09%-106.04% Which has more volatility & risk, CORBF or NAKA? Global Cord Blood has a beta of -0.6, indicating that its stock price is 160% less volatile than the S&P 500. Comparatively, KindlyMD has a beta of 31.1, indicating that its stock price is 3,010% more volatile than the S&P 500. Which has preferable valuation and earnings, CORBF or NAKA? Global Cord Blood has higher revenue and earnings than KindlyMD. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioGlobal Cord Blood$196.12M0.46$79.04MN/AN/AKindlyMD$2.72M142.59-$3.62M-$0.86-1.09 Does the media favor CORBF or NAKA? In the previous week, KindlyMD had 2 more articles in the media than Global Cord Blood. MarketBeat recorded 2 mentions for KindlyMD and 0 mentions for Global Cord Blood. Global Cord Blood's average media sentiment score of 0.00 equaled KindlyMD'saverage media sentiment score. Company Overall Sentiment Global Cord Blood Neutral KindlyMD Neutral SummaryKindlyMD beats Global Cord Blood on 6 of the 11 factors compared between the two stocks. Get Global Cord Blood News Delivered to You Automatically Sign up to receive the latest news and ratings for CORBF and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CORBF and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CORBF vs. The Competition Export to ExcelMetricGlobal Cord Bloodhealth & allied services, not elsewhere classified IndustryMedical SectorNYSE ExchangeMarket Cap$91.16M$69.93M$6.14B$22.09BDividend YieldN/AN/A5.66%3.59%P/E RatioN/A0.5985.8429.58Price / Sales0.460.44626.3664.95Price / Cash1.402.8038.3224.53Price / BookN/A0.1213.064.61Net Income$79.04M$43.11M$3.30B$1.01B7 Day Performance-25.00%-15.28%4.81%-0.46%1 Month Performance-28.57%-12.38%9.99%2.30%1 Year Performance-57.14%-1.01%85.28%14.51% Global Cord Blood Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CORBFGlobal Cord BloodN/A$0.75flatN/AN/A$91.16M$196.12M0.001,200NAKAKindlyMD1.7291 of 5 stars$1.07-8.5%$8.00+647.7%N/A$483.92M$2.72M-1.24N/AAnalyst ForecastAIRSAirSculpt Technologies0.9261 of 5 stars$8.02+6.4%$3.75-53.2%+67.3%$470.77M$180.35M-32.08240TALKTalkspace3.8044 of 5 stars$2.76flat$4.50+63.0%+25.3%$462.21M$202.61M138.07500News CoverageAnalyst DowngradeAGLAgilon Health2.3418 of 5 stars$1.03-7.2%$3.07+198.2%-65.9%$460.01M$6.06B-1.341,076News CoverageAnalyst ForecastSBCSBC Medical Group3.6733 of 5 stars$4.34+1.9%N/A-47.4%$442.53M$205.42M13.56N/AEHABEnhabit2.1241 of 5 stars$8.02-0.4%$8.67+8.1%+12.6%$408.06M$1.03B-3.0010,700News CoverageAnalyst ForecastTOIOncology Institute2.0925 of 5 stars$3.49+0.9%$7.00+100.6%+1,168.4%$323.53M$393.41M-5.13660Analyst ForecastLFMDLifeMD3.4834 of 5 stars$6.79+5.4%$13.17+93.9%+42.2%$305.37M$212.45M-32.33230Trending NewsAnalyst ForecastHigh Trading VolumeVMDViemed Healthcare2.2563 of 5 stars$6.79+2.6%N/A-18.6%$256.76M$224.26M19.971,179Positive NewsXGNExagen4.0411 of 5 stars$10.99+2.0%$12.00+9.2%+299.3%$236.98M$55.64M-12.35220News CoverageAnalyst ForecastHigh Trading Volume Related Companies and Tools Related Companies NAKA Competitors AIRS Competitors TALK Competitors AGL Competitors SBC Competitors EHAB Competitors TOI Competitors LFMD Competitors VMD Competitors XGN Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:CORBF) was last updated on 10/9/2025 by MarketBeat.com Staff From Our PartnersBitcoin grabs headlines, but smart money likes this tokenBitcoin grabs headlines, but smart money likes this token My research team has identified the token positio...Crypto 101 Media | SponsoredMagnificent 7 being replaced by the “Hidden 7”?BULLISH: It's time to buy this 'hidden' AI stock An award-winning stock-rating system has turned BULLISH on...Chaikin Analytics | SponsoredCapital Gains Tax Strategies for SeniorsCapital gains taxes can take a bite out of your retirement income—unless you have a smart strategy. From holdi...SmartAsset | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredAn $8 trillion-dollar discovery 17,000 ft underwater A strange rock pulled from the ocean floor may hold the key to a $16 trillion resource boom. Inside it: materi...Porter & Company | SponsoredFront-Run Buffett's Shocking Gold MoveA Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | Sponsored2013 miner reveals his trading systemWhile everyone else is gambling on meme coins or chasing the next "100x moonshot," our members are systematica...Crypto Swap Profits | SponsoredURGENT: The Market's 3 Red Flags Are FlashingHere’s the uncomfortable truth: The smartest investors in the world are already preparing for a crash befor...StockEarnings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Global Cord Blood Co. Please log in to your account or sign up in order to add this asset to your watchlist. Share Global Cord Blood With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
